Nephrocare Health Services Pvt. Ltd. Lists on NSE and BSE at 6-7% Premium; Closes Lower on First Day of Trading

Mumbai, December 17, 2025: Following its initial public offering, Nephrocare Health Services Limited was today listed on the stock exchanges. Nephrocare made a strong start in the secondary market opening at 6-7% premium on NSE and BSE.

Nephrocare Health Services Limited is essentially a healthcare service provider company, which includes services such as dialysis and renal care, provided under the brand name Nephroplus..

Nephrocare Health Services Listed on at 490.00 Per Share 

At the NSE, Nephrocare Health Services Limited (INE428V01029) debuted at ₹490 as against its issue price of ₹460. The stock was listed on the EQ segment and touched a high of ₹499.00 and a low of ₹463.80.

At the end of the day’s trade, the share was down by ₹17 or 3.47% at ₹471.25 from the opening price, but it was still up by ₹13 or 2.83% when compared to the issue price. Trading volume was 1.53 crore shares, and trading value stood at ₹742.5 crore. The daily VWAP stood at ₹483.65. 

The company’s market cap on NSE, as derived from the closing price, was ₹4,746.12 crore. The stock hit its 52-week high/low of 499.00/463.80 post listing.

Nephrocare Health Services List on BSE at ₹ 491.70 per share

Nephrocare Health Services Ltd (NEPHROPLUS | 544647 | INE428V01029) commenced trading on BSE at ₹491.70, as against its IPO issue price of ₹460. The stock touched a high of ₹498.70 and a low of ₹463.50 intraday.

The shares ended the day at Rs 471.60, 4.09% or ₹20.10 from its opening price but was up by ₹11.60 (about 2.52%) from its issue price. Total traded volume was 18.72 lakh shares and the gross turnover was Rs 90.95 crore.

At the close the entire market capitalization of the company listed on BSE stood at ₹4,732.07 crore and the free float market capitalization at ₹741.49 crore. 

Nephrocare Health IPO Recap

Nephrocare Health IPO was a book build issue of ₹871.05 crores. The issue was a combination of fresh issue of 0.77 crore shares aggregating to ₹353.60 crores and offer for sale of 1.13 crore shares aggregating to ₹517.45 crores. Nephrocare Health IPO bidding started from Dec 10, 2025, and ended on Dec 12, 2025.

 The allotment for Nephrocare Health IPO was finalised on Dec 15, 2025. The price band was set at ₹460.00 per share. The lot size for an application was 32. Nephrocare Health IPO was subscribed 14.08 times. The public issue subscribed 2.36 times in the retail category, 26.82 times in QIB (Ex Anchor), and 24.77 times in the NII category

Source: https://www.nseindia.com/get-quote/equity/NEPHROPLUS/Nephrocare-Health-Services-Limited

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur. 

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com. 

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations